New Era of Preventing End-Stage Kidney Disease Act
Latest Action
Referred to the Subcommittee on Health.
Official Summary
Official summary has not been imported yet.
GovScope Watchdog™
AI Government Intelligence™The New Era of Preventing End-Stage Kidney Disease Act (H.R. 6790) is a health policy bill introduced in the 118th Congress aimed at addressing the prevention of end-stage kidney disease. The bill was referred to the House Subcommittee on Health but did not advance further and is currently classified as failed or expired. Specific details about the bill's provisions, funding, or implementation mechanisms are not available in the provided data.
H.R. 6790 sought to improve prevention efforts for end-stage kidney disease but did not progress beyond subcommittee referral and is now expired without enactment.
- The bill focuses on preventing end-stage kidney disease, a significant public health issue.
- Introduced in the House during the 118th Congress and referred to the Subcommittee on Health.
- No further legislative action was taken, and the bill expired without becoming law.
['Patients at risk of or suffering from kidney disease', 'Healthcare providers specializing in kidney health', 'Public health agencies involved in chronic disease prevention']
['Lack of detailed information on funding and implementation may pose challenges for execution.', 'Absence of oversight or enforcement language in the available data limits understanding of accountability measures.', "The bill's failure to advance suggests potential legislative or policy hurdles."]
The bill was introduced in the House of Representatives during the 118th Congress and referred to the Subcommittee on Health. It did not progress further and is now classified as failed or expired. No additional legislative history or summary information is available to provide further context.
High concern review — 3 hidden impact flags detected
GovScope reviewed 3 policy-risk categories. Hover for a quick definition. Click detected flags for bill-specific details.
['Potential increased awareness and prioritization of kidney disease prevention in future legislative efforts.', 'Possible influence on public health agencies to develop or enhance kidney disease prevention programs independently.', 'Encouragement for healthcare providers to focus on early intervention strategies despite lack of new federal legislation.']
The absence of the full bill text and official summary limits transparency and comprehensive oversight. The bill's failure to progress beyond subcommittee referral restricts assessment of its potential impact and implementation feasibility. Future tracking of similar legislation would benefit from more complete documentation and clearer legislative actions.
GovScope Intelligence Roadmap
Future bill intelligence will connect sponsors, committee referrals, related votes, campaign finance, disclosures, and stock trades into one legislative intelligence view.